Tag: cardiomyopathy

19-CCC-6018-top10Innov-2019-3_650x450
November 8, 2019/Leadership Highlights

No. 3 Medical Innovation for 2020: Inaugural Medication for Transthyretin Amyloid Cardiomyopathy

Tafamidis is first FDA-approved drug to treat potentially fatal disease

19-HRT-3982-Tang-_CQD_650x450_2
September 13, 2019/Genomic Medicine

Cardiomyopathy Update: Progress on the Genetics Front and Beyond (Podcast)

New podcast episode ranges from genetics insights to patient selection for tafamidis

17-HRT-3687-Cardiomyopathy-Autoantibody-CQD
August 21, 2017/Research

Autoantibodies Point to Precision Approach in Systolic Heart Failure

Progress in quest for autoimmune mechanisms behind idiopathic dilated CM

30Transplant-690×380
August 20, 2015/News & Insights

30 Years of Heart Transplants: What a Patient Can Teach About the Constants Among the Changes

When a patient’s and a program’s 30-year anniversaries intersect

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

BackPage 1 of 1Next
Advertisement
Ad